SREBF1 and obesity disorder: In particular, Yang et al. [27] C/EBP/PPARγ/SREBP-1c and cAMP/PKA signaling pathways were regulated to confirm the anti-obesity and regulatory effects of (+)-catechin on lipid metabolism by inhibiting adipocyte differentiation.